The life sciences industry is undergoing a fundamental shift. Breakthroughs in precision medicine, gene therapy, and real-world evidence generation no longer happen inside a single laboratory or organization. They emerge from vibrant ecosystems where pharmaceutical companies, academic research centers, contract research organizations (CROs), hospital networks, and biotechnology startups must exchange vast, sensitive datasets at unprecedented…